TY - JOUR
T1 - Anti-angiogenic and anti-HER therapy
AU - Gasparini, Giampietro
AU - Sarmiento, Roberta
AU - Longo, Raffaele
PY - 2006/7
Y1 - 2006/7
N2 - The recent completion of the human genome sequence provided the basis and the tools to better understand the cellular biological complexity in both healthy and disease conditions, such as human cancer. In recent years, the improvement in biological and molecular knowledge enabled us to identify new targets and innovative drugs, allowing the beginning of new therapeutic strategies based on the so called "target oriented therapies".
AB - The recent completion of the human genome sequence provided the basis and the tools to better understand the cellular biological complexity in both healthy and disease conditions, such as human cancer. In recent years, the improvement in biological and molecular knowledge enabled us to identify new targets and innovative drugs, allowing the beginning of new therapeutic strategies based on the so called "target oriented therapies".
KW - Angiogenesis
KW - Molecular-target therapy
KW - Vascular endothelial growth factor (VEGF)
UR - http://www.scopus.com/inward/record.url?scp=33747097462&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747097462&partnerID=8YFLogxK
U2 - 10.1016/j.biopha.2006.06.001
DO - 10.1016/j.biopha.2006.06.001
M3 - Article
C2 - 16815667
AN - SCOPUS:33747097462
VL - 60
SP - 263
EP - 265
JO - Biomedicine and Pharmacotherapy
JF - Biomedicine and Pharmacotherapy
SN - 0753-3322
IS - 6
ER -